bedastOct 3, 2023

I hate everything about this headline.

#Diabetes #GLP1RA #GroundNews

Show threadbedast

To be clear: This is a diabetes drug first. It’s not a new drug class. One could consider me, personally, a “long term” study as I’ve been on a GLP-1 RA for over a decade. I still use one (albeit a newer one, Mounjaro) and it’s a required part of my T2D management.

Losing access to it because the masses think it’s a weight loss drug and consume all the supply means my management suffers.

Weight loss is off-label.

#Diabetes #T2D #GLP1RA #StopUsingMyDrugsOffLabel

Oct 3, 2023 at 3:25amWeb
Show threadbedastOct 3, 2023

One of the articles seems to indicate a study shows efficacy for up to 3 years.

This is interesting because this seems to fall in line with my weight loss/appetite modulation only lasting maybe 2 to 3 years.

But over a decade on this medication for it’s prescribed purpose…you know, the diabetes…management continues to be good with the latest version of these, Mounjaro. Even at max dose, my appetite is “normal”.

#Diabetes #T2D #GLP1RA #Ozempic #Mounjaro #Trulicity #Victoza